Thermo Fisher Scientific Inc. (TMO) trades at $700.22 on $259.44B of equity value, with a trailing P/E of 36.63. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.
Stocklytics score rationale: value 23, quality 52, growth 38.
AI Score 85. Thermo Fisher Scientific Inc. has a strong market capitalization of $257.7 billion and a solid net profit margin of approximately 15%
Summary
Thermo Fisher Scientific Inc. operates in Healthcare, within Medical - Diagnostics & Research. The company reports a net margin of 15.0% and a dividend yield of 0.3%.
Valuation
The shares trade at a P/E ratio of 37.2 and a price-to-book ratio of 4.8. These valuation measures provide limited context without growth, estimate, or price-trend data.
Quality
A net margin of 15.0% indicates the company retains profit after expenses. Additional balance-sheet, cash-flow, and return metrics are not provided.
Growth
No revenue, earnings-growth, or analyst-estimate figures are provided. Growth cannot be assessed from the available facts.
Risks
The P/E ratio of 37.2 and price-to-book ratio of 4.8 may leave the shares sensitive to changes in earnings expectations. No price-trend or forecast data is provided.